Revenues approx.16MM for the quarter almost 100% increase year over year for the quarter and EPS of 49 cents per share for the quarter, WOW!!!!!! This is a HUGE beat on REVS & EPS Watch the stock soar tomorrow.
GSK said last week that there Sales were down 61% in the 3rd quarter in China because of the government corruption investigation that is spooking doctors and hospitals from buying there products. GSK was a big supplier of Hepatitis Vaccine and Flu vaccine in China in the past. SVA will naturally sell more of these products as customers flee GSK to buy from other manufacturers who sale these products.